Variant Summary
- HGVS
- —
- Variant Type(s)
- loss_of_function_variant,protein_altering_variant
- Evidence Items
- 7
Evidence Level Distribution
Level A: 2Level B: 1Level C: 1Level D: 3
Evidence Items
Showing CIViC evidence rows where gene = NF1 and variant = Mutation.
| Level | Type | Direction | Significance | Disease | Drugs | Rating |
|---|---|---|---|---|---|---|
| A | Predictive | Supports | Sensitivity/Response | Plexiform Neurofibroma | Selumetinib | 4 |
| C | Predictive | Supports | Resistance | Skin Melanoma | Vemurafenib | 4 |
| D | Predictive | Supports | Sensitivity/Response | Skin Melanoma | Sirolimus,Mirdametinib | 3 |
| A | Predictive | Supports | Sensitivity/Response | Plexiform Neurofibroma | Selumetinib | 3 |
| B | Predictive | Supports | Sensitivity/Response | Childhood Low-grade Glioma | Selumetinib | 3 |
| D | Predictive | Supports | Resistance | Skin Melanoma | Vemurafenib | 2 |
| D | Predictive | Supports | Sensitivity/Response | Skin Melanoma | VTX-11e,AZ628 | 2 |